Benzinga

Benzinga

Benzinga

samedi, août 22

AC Immune SA

ACIUNASDAQ
Trade with Public
Trade with Public
$2.90
0.269.85%
À la clôture: Aug 21, 5:00 PM EST
$2.83
-0.0699-2.41%
Après les heures: 4:43 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerOptionsRapport sur les stocks

AC Immune Financials

AC Immune (ACIU) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
AC Immune Q1 EPS $(0.19) Beats $(0.20) Estimate, Sales $1.429M Beat $1.000M Estimate

AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 9.52 percent increase over losses of $(0.21) per share from the same
Benzinga Newsdesk

PRO
AC Immune Q4 EPS $(0.17) Beats $(0.19) Estimate, Sales $422.914K

AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 7.89 percent. This is a 2.78 percent increase over losses of $(0.18) per share from the same
Benzinga Newsdesk

PRO
AC Immune Q3 EPS $(0.20) Beats $(0.22) Estimate, Sales $1.174M Miss $1.520M Estimate

AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 433.33 percent decrease over earnings of $0.06 per share from the
Benzinga Newsdesk

PRO
AC Immune Q2 EPS $(0.21) Misses $(0.17) Estimate, Sales $1.54M Miss $1.98M Estimate

AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.17) by 20.69 percent. This is a 16 percent increase over losses of $(0.25) per share from the same
Benzinga Newsdesk

PRO
AC Immune Q1 EPS $(0.21) Misses $(0.20) Estimate, Sales $1.10M Beat $300.67K Estimate

AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.20) by 5 percent. This is unchanged from the same period last year. The company reported
Benzinga Newsdesk

PRO
AC Immune FY24 EPS CHF(0.51) vs CHF(0.64) YoY; Contract Revenues CHF27.3M

Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved